TickerFacts.

Neogen Corp (NEOG): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$31.90M
Year ended 2026-05-31
-10.1%
5-year compound annual growth
+4.2%
10-year compound annual growth
$61.83M2010-05-31: $22.56M2011-05-31: $21.05M2012-05-31: $9.86M2013-05-31: $17.66M2014-05-31: $10.12M2015-05-31: $34.17M2016-05-31: $21.11M2017-05-31: $45.70M2018-05-31: $48.19M2019-05-31: $49.18M2020-05-31: $61.83M2021-05-31: $54.38M2022-05-31: $43.61M2023-05-31: -$24.73M2024-05-31: -$76.10M2025-05-31: -$46.40M2026-05-31: $31.90M$31.90M
2010-05-31 Free Cash Flow (USD) 2026-05-31
Period endedFree Cash FlowChange YoYSource filing
2026-05-31$31.90Mn/m2026-07-30, From 2025-06-01
2025-05-31-$46.40Mn/m2026-07-30, From 2024-06-01
2024-05-31-$76.10Mn/m2026-07-30, From 2023-06-01
2023-05-31-$24.73Mn/m2025-07-30, From 2022-06-01
2022-05-31$43.61M-19.8%2024-07-30, From 2021-06-01
2021-05-31$54.38M-12.0%2023-08-15, From 2020-06-01
2020-05-31$61.83M+25.7%2022-07-27, From 2019-06-01
2019-05-31$49.18M+2.1%2021-07-30, From 2018-06-01
2018-05-31$48.19M+5.4%2020-07-30, From 2017-06-01
2017-05-31$45.70M+116.5%2019-07-30, From 2016-06-01
2016-05-31$21.11M-38.2%2018-07-27, From 2015-06-01
2015-05-31$34.17M+237.5%2017-07-28, From 2014-06-01
2014-05-31$10.12M-42.7%2016-07-29, From 2013-06-01
2013-05-31$17.66M+79.1%2015-07-30, From 2012-06-01
2012-05-31$9.86M-53.1%2014-07-30, From 2011-06-01
2011-05-31$21.05M-6.7%2013-07-30, From 2010-06-01
2010-05-31$22.56Mn/a2012-07-30, From 2009-06-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Neogen Corp (NEOG)2026-05-31$31.90Mn/m
QuidelOrtho Corp (QDEL)2025-12-28-$83.00Mn/m
Idexx Laboratories Inc (IDXX)2025-12-31$1.06B+30.8%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$395.87Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$9.79Mn/m
Immucell Corp (ICCC)2025-12-31$1.22Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.04Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$25.37Mn/m
Volitionrx Ltd (VNRX)2025-12-31-$19.77Mn/m

Compare NEOG, QDEL, IDXX, NTLA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗